To what extent do high-intensity statins reduce low-density lipoprotein cholesterol in each of the four statin benefit groups identified by the 2013 American College of Cardiology/American Heart Association guidelines? A VOYAGER meta-analysis-Reference-Cited by-同舟云学术

To what extent do high-intensity statins reduce low-density lipoprotein cholesterol in each of the four statin benefit groups identified by the 2013 American College of Cardiology/American Heart Association guidelines? A VOYAGER meta-analysis

Published:2015-08 Issue:2 Volume:241 Page:450-454
ISSN:0021-9150
Container-title:Atherosclerosis
language:en
Short-container-title:Atherosclerosis

Author:

Karlson Björn W.,Palmer Michael K.,Nicholls Stephen J.,Lundman Pia,Barter Philip J.

Funder

AstraZeneca

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference12 articles.

1. ESC/EAS Guidelines for the management of dyslipidaemias

2. An international atherosclerosis society position paper: global recommendations for the management of dyslipidemia;Expert Dyslipidemia Panel of the International Atherosclerosis Society Panel members;J. Clin. Lipidol.,2014

3. Treatment of blood cholesterol to reduce atherosclerotic cardiovascular disease risk in adults: synopsis of the 2013 ACC/AHA cholesterol guideline;Stone;J. Am. Coll. Cardiol.,2014

4. How do the 2013 cholesterol guidelines compare with previous cholesterol guideline reports?;Jackevicius;Circ. Cardiovasc Qual. Outcomes,2014

5. Meta-analysis of comparative efficacy of increasing dose of atorvastatin versus rosuvastatin versus simvastatin on lowering levels of atherogenic lipids (from VOYAGER);Nicholls;Am. J. Cardiol.,2010

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lipid-lowering Eeficacy and Safety of High Doses of Atorvastatin and Rosuvastatin;Kardiologiia;2023-02-28

2. Long-term outcomes of primary cardiovascular prevention: A retrospective study at a referral center in Portugal;Revista Portuguesa de Cardiologia;2022-08

3. A Comparative Study of High-intensity Rosuvastatin Versus Atorvastatin Therapy Post-acute Coronary Syndrome Using Real-world Data;Current Problems in Cardiology;2021-08

4. Is the effect of atorvastatin 60 mg on stabilization of lipid‐rich plaque equivalent to that of rosuvastatin 10 mg? A serial optical coherence tomography combined with intravascular ultrasound imaging;Catheterization and Cardiovascular Interventions;2021-04-17

5. Lipid-lowering therapy in patients with coronary artery disease in primary care practices: what has changed over 7 years?;Cardiovascular Therapy and Prevention;2020-09-05